Long-Term Efficacy of Erythropoiesis-Stimulating Agents in Patients with Low-Risk or Intermediate-1-Risk Myelodysplastic Syndrome: Multicenter Real-Life Data.

Published in:

Turkish Journal of Hematology, 2023, v. 40, n. 2, p. 92, doi. 10.4274/tjh.galenos.2023.2022.0437

By:

• Ak, Müzeyyen Aslaner;
• Gedük, Ayfer;
• Acar, İbrahim Halil;
• Polat, Merve Gökçen;
• Sunu, Cenk;
• Bolaman, Ali Zahit;
• Hacıbekiroğlu, Tuğba;
• Güvenç, Birol;
• Ertop, Şehmus

Publication type:

Article